Award
NIH Reporter #1R01FD008780-01
Intraperitoneal CAR T-cell therapy for peritoneal mesothelioma
Recipient
Sloan Kettering Institute for Cancer Research
Award Amount
$650,000.00
Ceiling
$650,000.00
Awarded
September 23, 2026
Identifier
1R01FD008780-01
The award supports a clinical trial evaluating the safety, dose, and efficacy of intraperitoneal CAR T-cell therapy for malignant peritoneal mesothelioma.
Description
Funding for a phase I clinical trial of autologous, intraperitoneally administered mesothelin-targeted CAR T cells with a PD1 dominant negative receptor strategy for patients with malignant peritoneal mesothelioma.